Novonesis Sees Strong Growth in 2024 and Promising 2025 Outlook
Novonesis Achieves Impressive Growth in 2024
Novonesis has showcased resilience and innovation in 2024, delivering an impressive 8% organic sales growth and an adjusted EBITDA margin of 36.1%. This strong financial performance is indicative of the company's robust strategies and innovative spirit.
Key Performance Highlights
The growth was notably supported by both Food & Health Biosolutions and Planetary Health Biosolutions, with volume increases contributing approximately 6%. Pricing adjustments accounted for the remaining 2% of sales growth in the year.
President & CEO Ester Baiget remarked, "2024 has been a truly remarkable year. While bringing together two extraordinary companies creating Novonesis, we’ve delivered strong performance across the business." These positive results underline Novonesis' capability to navigate challenging global conditions and capitalize on diverse opportunities.
Innovations and Sustainability Commitment
During the past year, Novonesis launched 45 innovative products. Impressively, around 30% of the company's 2024 sales came from products developed in the last five years, emphasizing their commitment to continued innovation.
Aligning with Global Goals
To further document their impact, Novonesis actively evaluates their contributions to the UN Sustainable Development Goals. In 2024, a remarkable 83% of sales were aligned with six of these goals. The company has notably reduced its Scope 1 and 2 CO2 emissions by 63% compared to 2018, alongside a revenue increase of over 25% during that timeframe.
Sales Performance by Division
Breaking down the performance, Food & Health Biosolutions witnessed a 7% organic growth, while Planetary Health Biosolutions excelled with 9% growth. In the Food & Health sector, Dairies and Baking saw robust gains, with organic sales in Food & Beverages rising by 8%.
Growth Across Categories
In Human Health, sales growth matched expectations with a 5% increase. Planetary Health’s Household Care segment thrived with a 13% rise, driven by enhanced market penetration and innovation. The Agriculture, Energy & Tech sector also delivered a solid 6% growth as double-digit increases in Energy bolstered overall performance.
Regional and Global Market Insights
Regionally, Novonesis reported a significant 12% organic growth in emerging markets, propelled by success across various sales areas. Developed markets displayed a commendable 6% growth, primarily fueled by advancements in Household Care and Food & Beverages.
Growth by Geography
The organic growth figures were even more impressive geographically, with rates of 15% in Latin America, 10% in Asia Pacific, 8% in Europe, and 5% in North America during 2024. These numbers reflect Novonesis' ability to navigate diverse markets and adjust their strategies effectively.
2025 Outlook: Optimism Abounds
Looking ahead, Novonesis is optimistic about continued growth in 2025, expecting organic sales growth of 5-8%. The forecast anticipates a stronger first half and includes significant reinvestments aimed at further expanding margins. Both Food & Health and Planetary Health Biosolutions divisions are projected to thrive within this growth range.
Financial Calendar for 2025
Key dates for the financial calendar in 2025 are as follows:
- Annual General Shareholders Meeting: April 3, 2025
- Q1 2025 Financial Results: May 8, 2025
- H1 2025 Financial Results: August 21, 2025
- Q3 2025 Financial Results: November 6, 2025
Media and Investor Relations Contacts
For more information, please reach out to:
Anne Sophie Scavenius
Senior Media Relations Manager
Phone: +45 30 77 19 67
Email: anse@novonesis.com
Tobias Cornelius Björklund
Head of Investor Relations
Phone: +45 30 77 86 82
Email: tobb@novonesis.com
Frequently Asked Questions
What are Novonesis’ growth expectations for 2025?
Novonesis anticipates organic sales growth of 5-8% in 2025, with significant reinvestments aimed at expanding margins further.
How much did Novonesis grow in 2024?
In 2024, Novonesis achieved an organic sales growth of 8% with an adjusted EBITDA margin of 36.1%.
What innovations did Novonesis launch in 2024?
Novonesis launched 45 new innovations in 2024, with about 30% of sales coming from products introduced within the last five years.
How does Novonesis contribute to sustainability?
In 2024, 83% of Novonesis’ sales were aligned with six UN Sustainable Development Goals, and the company has reduced its CO2 emissions significantly.
Who can I contact for media or investor relations inquiries?
For media inquiries, contact Anne Sophie Scavenius. For investor relations, reach out to Tobias Cornelius Björklund.
About The Author
Contact Henry Turner privately here. Or send an email with ATTN: Henry Turner as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.